Despite the fact that, in the past, treating critically ill patients with exogenous albumin to correct their hipoalbuminemia was not supposed to be beneficial, the current body of evidence indicates that hypoalbuminemia not only can contribute to the induction AKI, but also that human albumin administration has the potential to prevent AKI [15,16,17]. The gene discussed is ALB; the disease is Hypoalbuminemia.